Hassle free Returns FREE Shipping on orders above 500/- Cash On Delivery

Support 0484 4080450 | support@curegarden.in

Kerala Agriculture University grants 60 lakhs to Arjuna for product development using ginger’s active ingredient.

Posted on 27-12-16

While ginger is a pharmacologically important component in ginger, ginger has a slow content of gingerol. Curegarden parent company, Arjuna Natural Extract has been commissioned to develop high concentrate of gingerol extract through their scientific stabilization and purifying methods.

The Kerala Agricultural University (KAU) has launched a project on Public-Private Partnership (PPP) mode.It has signed a memorandum of understanding with private sector Arjuna Natural Extracts Limited for a project, ‘Metabolome analysis in ginger and product development using gingerol’.

Industrial feasibility

KAU Vice Chancellor P. Rajendran said the project was intended to take research findings to the industry. “Ginger has been used from time immemorial for therapeutic use. The KAU has developed several ginger varieties having high gingerol content. Gingerol being a pharmacologically important component in ginger with anti-inflammatory, analgesic, antipyretic, gastro-protective, cardiotonic and anti-hepatotoxic qualities, these KAU varieties are very useful in development of medicines with organic base,” he added.

T.R. Gopalakrishnan, Director of Research, said the project proposed under the PPP mode was funded by the Biotechnology Industry Research Council of the Union Department of Biotechnology.

The project will be jointly implemented by the Centre for Plant Biotechnology and Molecular Biology of KAU and the Arjuna Natural Extracts Limited, an ISO 9001 and 2200 Company.

The duration of the project is expected to be three years. The total outlay was Rs.14.8 crore, he said. Benny Antony, Founder Director, Arjuna Natural Extracts Limited, said that gingerol content was a vital parameter in production of ginger-based medicinal preparations, but its international market remained largely untapped because of the low gingerol content in traditional cultivars and poor gingerol stability issues.

“The novel ginger cultivars of KAU with high gingerol content will help commercialise quality guaranteed stable ginger extract by developing a ginger extract powder with at least 6 per cent gingerol content. The project will develop methods to increase the stability of gingerols in the product, identify and purify individual gingerols, and establish the safety of the standardised ginger extract. We had earlier collaborated with research institutions in the U.S. and Australia,” he added.

‘Boon to farmers’

M.R. Shylaja, professor, who detected the industrial feasibility of new ginger varieties with high gingerol content developed by her, said this project would be a boon to ginger farmers as it would lead to ensuring buy-back guarantee at fair price.

Default

ABOUT CURE GARDEN


Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bioactive compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanicals of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.


ABOUT ARJUNA NATURALS


Arjuna Natural Extracts Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.


FIND US ON FACEBOOK